Continuous monitoring of jugular bulb oxygen saturation and the effect of drugs acting on cerebral metabolism.

Ross Bullock, L. Stewart, C. Rafferty, G. M. Teasdale

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The laser absorption spectrophotometric technique was used to continuously monitor jugular bulb oxygen saturation (SjO2), and thus to calculate arteriovenous oxygen differences (AVDO2), in three subgroups of intensively monitored, severely head injured patients. We have used this data to address two questions: 1. How do cerebral and systemic haemodynamic changes affect SjO2 and AVDO2; and 2. Can ADVO2 measurements be used to detect therapeutic changes in brain metabolism, in response to drugs. The major haemodynamic factor affecting SjO2 and AVDO2 was intracranial pressure (ICP). Increases in ICP were associated with concomitant increases in SjO2, and decreases in AVDO2, suggesting cerebral hyperaemia in response to ICP waves. Systemic changes were less frequent, but potent influences on SjO2. The short acting anaesthetic agent propofol produced a marked increase in SjO2 (decrease in AVDO2 to below the normal range) which became less marked with time. A new high affinity glutamate antagonist produced no change in SjO2. With rigorous attention to technical factors, and exclusion of extra and intracranial haemodynamic effects, SjO2 monitoring may be a useful "surrogate end point" for the effect of drugs acting on brain metabolism.

Original languageEnglish
Pages (from-to)113-118
Number of pages6
JournalActa Neurochirurgica, Supplement
Volume59
StatePublished - Dec 1 1993
Externally publishedYes

Fingerprint

intracranial pressure
bulbs
hemodynamics
Hemodynamics
metabolism
Metabolism
drugs
Neck
Intracranial Pressure
Oxygen
saturation
brain
Monitoring
Brain
oxygen
Pharmaceutical Preparations
anesthetics
Excitatory Amino Acid Antagonists
Anesthetics
glutamates

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Neurology

Cite this

Continuous monitoring of jugular bulb oxygen saturation and the effect of drugs acting on cerebral metabolism. / Bullock, Ross; Stewart, L.; Rafferty, C.; Teasdale, G. M.

In: Acta Neurochirurgica, Supplement, Vol. 59, 01.12.1993, p. 113-118.

Research output: Contribution to journalArticle

Bullock, Ross ; Stewart, L. ; Rafferty, C. ; Teasdale, G. M. / Continuous monitoring of jugular bulb oxygen saturation and the effect of drugs acting on cerebral metabolism. In: Acta Neurochirurgica, Supplement. 1993 ; Vol. 59. pp. 113-118.
@article{72e128dac1ab4a36b96620fa10a20e0c,
title = "Continuous monitoring of jugular bulb oxygen saturation and the effect of drugs acting on cerebral metabolism.",
abstract = "The laser absorption spectrophotometric technique was used to continuously monitor jugular bulb oxygen saturation (SjO2), and thus to calculate arteriovenous oxygen differences (AVDO2), in three subgroups of intensively monitored, severely head injured patients. We have used this data to address two questions: 1. How do cerebral and systemic haemodynamic changes affect SjO2 and AVDO2; and 2. Can ADVO2 measurements be used to detect therapeutic changes in brain metabolism, in response to drugs. The major haemodynamic factor affecting SjO2 and AVDO2 was intracranial pressure (ICP). Increases in ICP were associated with concomitant increases in SjO2, and decreases in AVDO2, suggesting cerebral hyperaemia in response to ICP waves. Systemic changes were less frequent, but potent influences on SjO2. The short acting anaesthetic agent propofol produced a marked increase in SjO2 (decrease in AVDO2 to below the normal range) which became less marked with time. A new high affinity glutamate antagonist produced no change in SjO2. With rigorous attention to technical factors, and exclusion of extra and intracranial haemodynamic effects, SjO2 monitoring may be a useful {"}surrogate end point{"} for the effect of drugs acting on brain metabolism.",
author = "Ross Bullock and L. Stewart and C. Rafferty and Teasdale, {G. M.}",
year = "1993",
month = "12",
day = "1",
language = "English",
volume = "59",
pages = "113--118",
journal = "Scientific Computing and Instrumentation",
issn = "1078-8956",
publisher = "Springer Wien",

}

TY - JOUR

T1 - Continuous monitoring of jugular bulb oxygen saturation and the effect of drugs acting on cerebral metabolism.

AU - Bullock, Ross

AU - Stewart, L.

AU - Rafferty, C.

AU - Teasdale, G. M.

PY - 1993/12/1

Y1 - 1993/12/1

N2 - The laser absorption spectrophotometric technique was used to continuously monitor jugular bulb oxygen saturation (SjO2), and thus to calculate arteriovenous oxygen differences (AVDO2), in three subgroups of intensively monitored, severely head injured patients. We have used this data to address two questions: 1. How do cerebral and systemic haemodynamic changes affect SjO2 and AVDO2; and 2. Can ADVO2 measurements be used to detect therapeutic changes in brain metabolism, in response to drugs. The major haemodynamic factor affecting SjO2 and AVDO2 was intracranial pressure (ICP). Increases in ICP were associated with concomitant increases in SjO2, and decreases in AVDO2, suggesting cerebral hyperaemia in response to ICP waves. Systemic changes were less frequent, but potent influences on SjO2. The short acting anaesthetic agent propofol produced a marked increase in SjO2 (decrease in AVDO2 to below the normal range) which became less marked with time. A new high affinity glutamate antagonist produced no change in SjO2. With rigorous attention to technical factors, and exclusion of extra and intracranial haemodynamic effects, SjO2 monitoring may be a useful "surrogate end point" for the effect of drugs acting on brain metabolism.

AB - The laser absorption spectrophotometric technique was used to continuously monitor jugular bulb oxygen saturation (SjO2), and thus to calculate arteriovenous oxygen differences (AVDO2), in three subgroups of intensively monitored, severely head injured patients. We have used this data to address two questions: 1. How do cerebral and systemic haemodynamic changes affect SjO2 and AVDO2; and 2. Can ADVO2 measurements be used to detect therapeutic changes in brain metabolism, in response to drugs. The major haemodynamic factor affecting SjO2 and AVDO2 was intracranial pressure (ICP). Increases in ICP were associated with concomitant increases in SjO2, and decreases in AVDO2, suggesting cerebral hyperaemia in response to ICP waves. Systemic changes were less frequent, but potent influences on SjO2. The short acting anaesthetic agent propofol produced a marked increase in SjO2 (decrease in AVDO2 to below the normal range) which became less marked with time. A new high affinity glutamate antagonist produced no change in SjO2. With rigorous attention to technical factors, and exclusion of extra and intracranial haemodynamic effects, SjO2 monitoring may be a useful "surrogate end point" for the effect of drugs acting on brain metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0027758395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027758395&partnerID=8YFLogxK

M3 - Article

C2 - 7906076

AN - SCOPUS:0027758395

VL - 59

SP - 113

EP - 118

JO - Scientific Computing and Instrumentation

JF - Scientific Computing and Instrumentation

SN - 1078-8956

ER -